These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 8841204)
1. Antepartum screening in the office-based practice: findings from the collaborative Ambulatory Research Network. Wilkins-Haug L; Horton JA; Cruess DF; Frigoletto FD Obstet Gynecol; 1996 Oct; 88(4 Pt 1):483-9. PubMed ID: 8841204 [TBL] [Abstract][Full Text] [Related]
2. A prospective evaluation of a second-trimester screening test for fetal Down syndrome using maternal serum alpha-fetoprotein, hCG, and unconjugated estriol. Cheng EY; Luthy DA; Zebelman AM; Williams MA; Lieppman RE; Hickok DE Obstet Gynecol; 1993 Jan; 81(1):72-7. PubMed ID: 7677967 [TBL] [Abstract][Full Text] [Related]
3. Maternal serum screening for Down's syndrome, open neural tube defects and trisomy 18. Akbas SH; Ozben T; Alper O; Ugur A; Yücel G; Lüleci G Clin Chem Lab Med; 2001 Jun; 39(6):487-90. PubMed ID: 11506458 [TBL] [Abstract][Full Text] [Related]
4. 'Dual positivity' for neural tube defects and down syndrome at maternal serum screening: gestational outcome. Zanini R; Tarantini M; Cerri V; Jacobello C; Bellotti D; Lancetti S; Scalchi S; Groli C; Bianchi UA Fetal Diagn Ther; 1998; 13(2):106-10. PubMed ID: 9650657 [TBL] [Abstract][Full Text] [Related]
6. Prenatal screening using maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol: two-year experience in a health maintenance organization. McDuffie RS; Haverkamp AD; Stark CF; Haverkamp C; Barth CK J Matern Fetal Med; 1996; 5(2):70-3. PubMed ID: 8796771 [TBL] [Abstract][Full Text] [Related]
7. Maternal serum screening for fetal Down syndrome in women less than 35 years of age using alpha-fetoprotein, hCG, and unconjugated estriol: a prospective 2-year study. Phillips OP; Elias S; Shulman LP; Andersen RN; Morgan CD; Simpson JL Obstet Gynecol; 1992 Sep; 80(3 Pt 1):353-8. PubMed ID: 1379701 [TBL] [Abstract][Full Text] [Related]
8. Elevated maternal urine level of beta-core fragment of human chorionic gonadotropin versus serum triple test in the second-trimester detection of down syndrome. Bahado-Singh R; Oz U; Rinne K; Hunter D; Cole L; Mahoney MJ; Baumgarten A Am J Obstet Gynecol; 1999 Oct; 181(4):929-33. PubMed ID: 10521756 [TBL] [Abstract][Full Text] [Related]
9. Down syndrome and neural tube defect screening: the value of using gestational age by ultrasonography. Benn PA; Borgida A; Horne D; Briganti S; Collins R; Rodis JF Am J Obstet Gynecol; 1997 May; 176(5):1056-61. PubMed ID: 9166168 [TBL] [Abstract][Full Text] [Related]
10. Prenatal screening for fetal aneuploidy in singleton pregnancies. Chitayat D; Langlois S; Douglas Wilson R; ; J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752 [TBL] [Abstract][Full Text] [Related]
12. Maternal serum screening in Ontario using the triple marker test. Summers AM; Farrell SA; Huang T; Meier C; Wyatt PR J Med Screen; 2003; 10(3):107-11. PubMed ID: 14561260 [TBL] [Abstract][Full Text] [Related]
13. Maternal serum triple analyte screening in pregnancy. Graves JC; Miller KE; Sellers AD Am Fam Physician; 2002 Mar; 65(5):915-20. PubMed ID: 11898965 [TBL] [Abstract][Full Text] [Related]
14. Triple marker screening for trisomy 21, trisomy 18 and open neural tube defects in singleton pregnancies of native Japanese pregnant women. Onda T; Tanaka T; Yoshida K; Nakamura Y; Kudo R; Yamamoto H; Sato A; Yanagida K; Takai Y; Uemura H; Hoshi K; Fukada Y; Miyake Y; Ohnishi M; Kaneoka T; Makino Y; Murata Y; Kanzaki T; Kanzaki H; Osaki T; Aono T; Maeda K; Ogita S; Yamamasu S; Aso T; Shimizu Y; Izutsu T; Kudo T; Okai T; Sakai M; Hashimoto T; Matsuzaki N; Kitagawa M; Sago H; Grier RE; Myrick F; Shimizu Y J Obstet Gynaecol Res; 2000 Dec; 26(6):441-7. PubMed ID: 11152330 [TBL] [Abstract][Full Text] [Related]
15. Participation in maternal serum screening for Down syndrome, neural tube defects, and trisomy 18 following screen-positive results in a previous pregnancy. Rausch DN; Lambert-Messerlian GM; Canick JA West J Med; 2000 Sep; 173(3):180-3. PubMed ID: 10986181 [TBL] [Abstract][Full Text] [Related]
16. [The triple-serum test for detection of Down syndrome and neural tube defects; the problem of a risk assessment test]. van den Boer-van den Berg JM; Dupuis HM Ned Tijdschr Geneeskd; 1993 Jun; 137(26):1286-9. PubMed ID: 7688445 [No Abstract] [Full Text] [Related]
17. Periodic health examination, 1996 update: 1. Prenatal screening for and diagnosis of Down syndrome. Canadian Task Force on the Periodic Health Examination. Dick PT CMAJ; 1996 Feb; 154(4):465-79. PubMed ID: 8630836 [TBL] [Abstract][Full Text] [Related]
18. Double-positive maternal serum screening results for down syndrome and open neural tube defects: An indicator for fetal structural or chromosomal abnormalities and adverse obstetric outcomes. Chitayat D; Farrell SA; Huang T; Meier C; Wyatt PR; Summers AM Am J Obstet Gynecol; 2002 Sep; 187(3):758-63. PubMed ID: 12237660 [TBL] [Abstract][Full Text] [Related]
19. Maternal serum screening of Palestinian women in the West Bank. Husseini A; Akkawi M East Mediterr Health J; 2005 Jul; 11(4):824-7. PubMed ID: 16700399 [TBL] [Abstract][Full Text] [Related]
20. Effect of normal MSAFP screening on maternal age for genetic amniocentesis. Ganiats TG; Berry CC; Fullerton JT J Clin Epidemiol; 1990; 43(11):1143-8. PubMed ID: 1700812 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]